房颤血栓的治疗 PPT课件

有任何高危因素或至少2 个中危因素患者者Р无危险因素为何可以接受?阿斯匹林 325mg/dР原发事件(缺血卒中,致残,TIA)? 卒中/栓塞?2.2%/年?(95% CI 1.6-3.0%)? 颅内出血?0.1%/年,?非CNS出血 0.6%/年Р高血压史(46%) 有?无? 年事件率?3.6%?1.1%? 致残卒中?1.4%?0.5%РSPAF III 亚组--低危防治血栓(n=892) AF<1年内无危险因素,?之后6.5%出现危险因素,改药。共随诊 2 年Р华法调整剂量与安慰剂比较РAFASAKI (1)?SPAF (3)?BAATAF(9)?CAFA (14)?SPINAF (13)?EAFT (16)?All Trials (n=6)Р100%Р-50%Р50%Р-100%Р0РWarfarin BetterРWarfarin WorseРRelative Risk Reduction?(95% CI)Р阿斯匹林与安慰剂比较Р100%Р-50%Р50%Р-100%Р0РWarfarin BetterРWarfarin WorseРAFASAKI (1)?SPAF I (3)?EAFT (9)?ESPS II (14)?LASAF (13)?UK-TIA (16)?All Trials (n=6)РRelative Risk Reduction?(95% CI)Р华法令与阿斯匹林比较Рparedwith AspirinР100%Р-50%Р50%Р-100%Р0РWarfarin BetterРWarfarin WorseРAFASAK I (1)?AFASAK II (2)?EAFT(9)?PATAF (15)?SPAF II (4)?All Trials (n=5)РRelative Risk Reduction?(95% CI)Р华法令,阿斯匹林与安慰剂的比较